Research Plan Assessments and Quality Program Support

As clinical research activities begin to restart with COVID-19 related public health precautions in place, how will this new normal impact individual protocols and your research portfolio?

To determine which research projects can restart and how, it is important to conduct a feasibility assessment and ensure compliant processes and documentation are in place—with considerations for remote or virtual modalities.

Advarra is here to help you establish plans for restarting your trials with:

• Portfolio prioritization
• Program and protocol feasibility and risk assessment
• Key stakeholder and decision maker identification and communication strategies with these groups
• Developing a business continuity plan for your research program to enable management of shifting capabilities
  

Evaluate how COVID-19 has affected your study conduct, build new processes for your research program moving forward, and ensure stakeholders are informed of research restart plans with our proactive, collaborative consulting team. Fill out this form to get started.